A description of the correction of data error and the direction of in-depth research
Jian Xiong,Weiling Yin,Xilin Du,Zhonghua Luo
DOI: https://doi.org/10.21037/jgo-24-89
2024-04-30
Journal of Gastrointestinal Oncology
Abstract:Jian Xiong, Weiling Yin, Xilin Du, Zhonghua Luo Department of Interventional Radiology, Tangdu Hospital, The Fourth Military Medical University, Xi'an, China Response to: Dai Y, Yu C, Feng Q. Is brachial artery approach safe for hepatic artery infusion chemotherapy? J Gastrointest Oncol 2024;15:805-6. Submitted Feb 01, 2024. Accepted for publication Mar 29, 2024. Published online Apr 28, 2024. doi: 10.21037/jgo-24-89 First of all, we would like to express our sincere gratitude to Dai et al. for their comments and corrections on this article (1,2). Secondly, the 1.65 treatments appearing in the results should be corrected to 2.59 treatments. We sincerely apologize for this error, and hope the editors would correct this as soon as possible. However, there is no impact on the reliability of the article's conclusion with this correction. Thirdly, as a descriptive study, this article only described and summarized the results of the surgical success rate and postoperative complication rate of cases undergoing the brachial artery (TBA) approach, and preliminarily explained the feasibility and safety of this surgical method. More in-depth and rigorous clinical studies are indeed needed, which has been mentioned in the limitations of the study. Finally, the study needs to expand the sample size in the future, collect more indicators such as patients' basic conditions and status of the disease, evaluation on the comfort level, time and dose of radiation exposure to the surgeon and the patient, then to conduct a randomized controlled trial with the surgical method in the traditional transfemoral approach (TFA), and provide actual surgical pictures, to fully explain the safety and advantages of the surgical method and provide reference for clinical practice. Thanks again to Dai et al. for their comments and corrections and to the editors for their work! Funding: None. Provenance and Peer Review: This article was commissioned by the editorial office, Journal of Gastrointestinal Oncology. The article did not undergo external peer review. Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-24-89/coif). All authors have no conflicts of interest to declare. Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
oncology,gastroenterology & hepatology